APA (7th ed.) Citation

A, B., F, L., MG, C., S, M., R, G., S, M., . . . MT, L. (2026). The conditional benefit of being alive and disease free at 2 years after transplant: A long term survival evaluation among 456 patients affected by acute myeloid leukemia. Frontiers in immunology, 17, 1818603. https://doi.org/10.3389/fimmu.2026.1818603

Chicago Style (17th ed.) Citation

A, Bruno, et al. "The Conditional Benefit of Being Alive and Disease Free at 2 Years After Transplant: A Long Term Survival Evaluation Among 456 Patients Affected by Acute Myeloid Leukemia." Frontiers in Immunology 17 (2026): 1818603. https://doi.org/10.3389/fimmu.2026.1818603.

MLA (9th ed.) Citation

A, Bruno, et al. "The Conditional Benefit of Being Alive and Disease Free at 2 Years After Transplant: A Long Term Survival Evaluation Among 456 Patients Affected by Acute Myeloid Leukemia." Frontiers in Immunology, vol. 17, 2026, p. 1818603, https://doi.org/10.3389/fimmu.2026.1818603.